Latest developments in allergic rhinitis in Allergy for clinicians and researchers

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 12, 2015, Pages 1521-1530

  Ng, C L ^a   Wang, D Y ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Allergic rhinitis; asthma; atopic dermatitis; epidemiology; genetics; management

Indexed keywords

ALLERGEN; FINGOLIMOD; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 10; INTERLEUKIN 12; OC 000459; RETINOL; UNCLASSIFIED DRUG; VITAMIN D;

ACUPUNCTURE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; CHRONIC RHINOSINUSITIS; COMORBIDITY; CYTOKINE RELEASE; DAILY LIFE ACTIVITY; ECZEMA; HEALTH CARE COST; HUMAN; IMMUNOTHERAPY; INFORMATION TECHNOLOGY; POPULATION GENETICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; RISK FACTOR; SENSITIZATION; VITAMIN SUPPLEMENTATION; WHEEZING; IMMUNOLOGY; TRENDS;

ALLERGY AND IMMUNOLOGY; HUMANS; RHINITIS, ALLERGIC;

EID: 84957805315     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12782     Document Type: Article

References (114)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl 86): 8-160.
2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351 (9111): 1225-1232.
3. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J,. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64: 123-148.
4. Morais-Almeida M, Santos N, Pereira AM, Branco-Ferreira M, Nunes C, Bousquet J, et al., Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. Allergy 2013; 68: 1278-1288.
5. Chong Neto HJ, Rosário CS, Rosário BA, Chong FH, Grasselli EA, Silva FC, et al., Allergic rhinitis in preschool children from southern Brazil. Allergy 2014; 69: 545-547.
6. Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, et al., Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2013; 68: 1102-1116.
7. Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK,. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 2014; 69: 1275-1279.
8. Jutel M, Angier L, Palkonen S, Ryan D, Sheikh A, Smith H, et al., Improving allergy management in the primary care network-a holistic approach. Allergy 2013; 68: 1362-1369.
9. Vuurman EF, Vuurman LL, Lutgens I, Kremer B,. Allergic rhinitis is a risk factor for traffic safety. Allergy 2014; 69: 906-912.
10. Su VYF, Liu CJ, Lan MY, Chen YM, Su KC, Lee YC, et al., Allergic rhinitis and risk of erectile dysfunction-a nationwide population-based study. Allergy 2013; 68: 440-445.
11. Deliu M, Belgrave D, Simpson A, Murray CS, Kerry G, Custovic A,. Impact of rhinitis on asthma severity in school-age children. Allergy 2014; 69: 1515-1521.
12. Yilmaz O, Bakirtas A, Ertoy Karagol HI, Topal E, Demirsoy MS,. Allergic rhinitis may impact the recovery of pulmonary function tests after moderate/severe asthma exacerbation in children. Allergy 2014; 69: 652-657.
13. Lohia S, Schlosser RJ, Soler ZM,. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy 2013; 68: 569-579.
14. Georgalas C, Vlastos I, Picavet V, van Drunen C, Garas G, Prokopakis E,. Is chronic rhinosinusitis related to allergic rhinitis in adults and children? Applying epidemiological guidelines for causation. Allergy 2014; 69: 828-833.
15. Tischer CG, Gref A, Standl M, Bauer M, Bergstrom A, Brauer M, et al., Glutathione-S-transferase P1, early exposure to mould in relation to respiratory and allergic health outcomes in children from six birth cohorts. A meta-analysis. Allergy 2013; 68: 339-346.
16. Nilsson D, Henmyr V, Hallden C, Sall T, Kull I, Wickman M, et al., Replication of genomewide associations with allergic sensitization and allergic rhinitis. Allergy 2014; 69: 1506-1514.
17. Tomita K, Sakashita M, Hirota T, Tanaka S, Masuyama K, Yamada T, et al., Variants in the 17q21 asthma susceptibility locus are associated with allergic rhinitis in the Japanese population. Allergy 2013; 68: 92-100.
18. Kono M, Nomura T, Ohguchi Y, Mizuno O, Suzuki S, Tsujiuchi H, et al., Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations. Allergy 2014; 69: 537-540.
19. Amaral AF, Minelli C, Guerra S, Wjst M, Probst-Hensch N, Pin I, et al., The locus C11orf30 increases susceptibility to poly-sensitization. Allergy 2015; 70: 328-333.
20. Casaca VI, Illi S, Klucker E, Ballenberger N, Schedel M, von Mutius E, et al., STAT6 polymorphisms are associated with neonatal regulatory T cells and cytokines and atopic diseases at 3 years. Allergy 2013; 68: 1249-1258.
21. Sharma V, Michel S, Gaertner V, Franke A, Vogelberg C, von Berg A, et al., A role of FCER1A and FCER2 polymorphisms in IgE regulation. Allergy 2014; 69: 231-236.
22. Kretschmer A, Moller G, Lee H, Laumen H, von Toerne C, Schramm K, et al., A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. Allergy 2014; 69: 632-642.
23. Sharma V, Michel S, Gaertner V, Franke A, Vogelberg C, von Berg A, et al., Fine-mapping of IgE-associated loci 1q23, 5q31, and 12q13 using 1000 Genomes Project data. Allergy 2014; 69: 1077-1084.
24. Schieck M, Sharma V, Michel S, Toncheva AA, Worth L, Potaczek DP, et al., A polymorphism in the TH 2 locus control region is associated with changes in DNA methylation and gene expression. Allergy 2014; 69: 1171-1180.
25. Sahiner UM, Semic-Jusufagic A, Curtin JA, Birben E, Belgrave D, Sackesen C, et al., Polymorphisms of endotoxin pathway and endotoxin exposure: in vitro IgE synthesis and replication in a birth cohort. Allergy 2014; 69: 1648-1658.
26. Butsch Kovacic M, Martin LJ, Biagini MJ, He H, Lindsey M, Mersha TB, et al., Genetic approach identifies distinct asthma pathways in overweight vs normal weight children. Allergy 2015; 70: 1028-1032.
27. Haj-Salem I, Fakhfakh R, Berube JC, Jacques E, Plante S, Simard MJ, et al., MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFbetaR2 gene in severe asthma. Allergy 2015; 70: 212-219.
28. Kreiner-Moller E, Strachan DP, Linneberg A, Husemoen LL, Bisgaard H, Bonnelykke K,. 17q21 gene variation is not associated with asthma in adulthood. Allergy 2015; 70: 107-114.
29. Ried JS, Baurecht H, Stuckler F, Krumsiek J, Gieger C, Heinrich J, et al., Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 2013; 68: 629-636.
30. Izuhara Y, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, et al., GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids. Allergy 2014; 69: 668-673.
31. van der Valk RJ, Kiefte-de Jong JC, Sonnenschein-van der Voort AM, Duijts L, Hafkamp-de Groen E, Moll HA, et al., Neonatal folate, homocysteine, vitamin B12 levels and methylenetetrahydrofolate reductase variants in childhood asthma and eczema. Allergy 2013; 68: 788-795.
32. Wang SS, Hon KL, Kong AP, Tang MF, Sy HY, Chan JC, et al., Eczema phenotypes are associated with multiple vitamin D pathway genes in Chinese children. Allergy 2014; 69: 118-124.
33. Casas L, Sunyer J, Tischer C, Gehring U, Wickman M, Garcia-Esteban R, et al., Early-life house dust mite allergens, childhood mite sensitization, and respiratory outcomes. Allergy 2015; 70: 820-827.
34. Newson RB, van Ree R, Forsberg B, Janson C, Lotvall J, Dahlen SE, et al., Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey. Allergy 2014; 69: 643-651.
35. Toppila-Salmi S, Huhtala H, Karjalainen J, Renkonen R, Mäkelä MJ, Wang DY, et al., Sensitization pattern affects the asthma risk in Finnish adult population. Allergy 2015; 70: 1112-1120.
36. Andiappan AK, Puan KJ, Lee B, Nardin A, Poidinger M, Connolly J, et al., Allergic airway diseases in a tropical urban environment are driven by dominant mono-specific sensitization against house dust mites. Allergy 2014; 69: 501-509.
37. Bjerg A, Ronmark EP, Hagstad S, Eriksson J, Andersson M, Wennergren G, et al., Gas, dust, and fumes exposure is associated with mite sensitization and with asthma in mite-sensitized adults. Allergy 2015; 70: 604-607.
38. Post S, Nawijn MC, Jonker MR, Kliphuis N, van den Berge M, van Oosterhout AJ, et al., House dust mite-induced calcium signaling instigates epithelial barrier dysfunction and CCL20 production. Allergy 2013; 68: 1117-1125.
39. Wimmer M, Alessandrini F, Gilles S, Frank U, Oeder S, Hauser M, et al., Pollen-derived adenosine is a necessary cofactor for ragweed allergy. Allergy 2015; 70: 944-954.
40. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ,. Atopic dermatitis and the atopic march revisited. Allergy 2014; 69: 17-27.
41. Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagaña X, Smit HA, et al., Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy 2015; 70: 973-984.
42. Westman M, Kull I, Lind T, Melén E, Stjärne P, Toskala E, et al., The link between parental allergy and offspring allergic and nonallergic rhinitis. Allergy 2013; 68: 1571-1578.
43. Fuertes E, Standl M, von Berg A, Lehmann I, Hoffmann B, Bauer CP, et al., Parental allergic disease before and after child birth poses similar risk for childhood allergies. Allergy 2015; 70: 873-876.
44. Andersson NAW, Hansen MV, Larsen AD, Hougaard KS, Kolstad HA, Schlünssen V,. Prenatal maternal stress and atopic diseases in the child: a systematic review of observational human studies. Allergy 2015. doi: 10.1111/all.12762.
45. Macchiaverni P, Rekima A, Turfkruyer M, Mascarell L, Airouche S, Moingeon P, et al., Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma. Allergy 2014; 69: 395-398.
46. Mai XM, Chen Y, Camargo CA, Langhammer A,. Serum 25-hydroxyvitamin D levels and self-reported allergic rhinitis in Norwegian adults-The HUNT Study. Allergy 2014; 69: 488-493.
47. Heimbeck I, Wjst M, Apfelbacher CJ,. Low vitamin D serum level is inversely associated with eczema in children and adolescents in Germany. Allergy 2013; 68: 906-910.
48. Vasiliou JE, Lui S, Walker SA, Chohan V, Xystrakis E, Bush A, et al., Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease. Allergy 2014; 69: 1380-1389.
49. Cassim R, Russell MA, Lodge CJ, Lowe AJ, Koplin JJ, Dharmage SC,. The role of circulating 25 hydroxyvitamin D in asthma: a systematic review. Allergy 2015; 70: 339-354.
50. Confino-Cohen R, Brufman I, Goldberg A, Feldman BS,. Vitamin D, asthma prevalence and asthma exacerbations: a large adult population-based study. Allergy 2014; 69: 1673-1680.
51. Aage S, Kiraly N, Da Costa K, Byberg S, Bjerregaard-Andersen M, Fisker AB, et al., Neonatal vitamin A supplementation associated with increased atopy in girls. Allergy 2015; 70: 985-994.
52. Kiraly N, Benn CS, Biering-Sorensen S, Rodrigues A, Jensen KJ, Ravn H, et al., Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long-term follow-up of a randomized controlled trial. Allergy 2013; 68: 1168-1176.
53. Nwaru BI, Virtanen SM, Alfthan G, Karvonen AM, Genuneit J, Lauener RP, et al., Serum vitamin E concentrations at 1 year and risk of atopy, atopic dermatitis, wheezing, and asthma in childhood: the PASTURE study. Allergy 2014; 69: 87-94.
54. Ruokolainen L, von Hertzen L, Fyhrquist N, Laatikainen T, Lehtomäki J, Auvinen P, et al., Green areas around homes reduce atopic sensitization in children. Allergy 2015; 70: 195-202.
55. Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R,. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 2015; 70: 241-244.
56. Michel S, Busato F, Genuneit J, Pekkanen J, Dalphin JC, Riedler J, et al., Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy 2013; 68: 355-364.
57. MacNeill SJ, Sozanska B, Danielewicz H, Debinska A, Kosmeda A, Boznanski A, et al., Asthma and allergies: is the farming environment (still) protective in Poland? The GABRIEL Advanced Studies. Allergy 2013; 68: 771-779.
58. Sozanska B, Pearce N, Blaszczyk M, Boznanski A, Cullinan P,. Changes in atopy prevalence and sibship effect in rural population at all ages. Allergy 2015; 70: 661-666.
59. Hahm MI, Chae Y, Kwon HJ, Kim J, Ahn K, Kim WK, et al., Do newly built homes affect rhinitis in children? The ISAAC phase III study in Korea. Allergy 2014; 69: 479-487.
60. Bowatte G, Lodge C, Lowe AJ, Erbas B, Perret J, Abramson MJ, et al., The influence of childhood traffic-related air pollution exposure on asthma, allergy and sensitization: a systematic review and a meta-analysis of birth cohort studies. Allergy 2015; 70: 245-256.
61. Bertelsen RJ, Longnecker MP, Lovik M, Calafat AM, Carlsen KH, London SJ, et al., Triclosan exposure and allergic sensitization in Norwegian children. Allergy 2013; 68: 84-91.
62. Eriksson J, Ekerljung L, Sundblad BM, Lotvall J, Toren K, Ronmark E, et al., Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy 2013; 68: 347-354.
63. Ferrari M, Pesce G, Marcon A, Vallerio P, Fratta Pasini AM, de Marco R,. Rhinitis is associated with a greater risk of intermittent claudication in adults. Allergy 2014; 69: 472-478.
64. Wong KJ, Timbrell V, Xi Y, Upham JW, Collins AM, Davies JM,. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis. Allergy 2015; 70: 420-428.
65. Oeder S, Alessandrini F, Wirz OF, Braun A, Wimmer M, Frank U, et al., Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells. Allergy 2015; 70: 1450-1460.
66. Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, et al., Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy 2013; 68: 312-321.
67. Dong J, Wong CK, Cai Z, Jiao D, Chu M, Lam CW,. Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy 2015; 70: 921-932.
68. Siebenhaar F, Falcone FH, Tiligada E, Hammel I, Maurer M, Sagi-Eisenberg R, et al., The search for mast cell and basophil models-are we getting closer to pathophysiological relevance? Allergy 2015; 70: 1-5.
69. Gibbs BF, Nilsson GP,. Basophils unlimited. Allergy 2013; 68: 553-554.
70. Blank U, Falcone FH, Nilsson G,. The history of mast cell and basophil research-some lessons learnt from the last century. Allergy 2013; 68: 1093-1101.
71. Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, et al., The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy 2015; 70: 1393-1405.
72. Ando N, Nakamura Y, Ishimaru K, Ogawa H, Okumura K, Shimada S, et al., Allergen-specific basophil reactivity exhibits daily variations in seasonal allergic rhinitis. Allergy 2015; 70: 319-322.
73. Nakao A, Nakamura Y, Shibata S,. The circadian clock functions as a potent regulator of allergic reaction. Allergy 2015; 70: 467-473.
74. Shamji MH, Bellido V, Scadding GW, Layhadi JA, Cheung DK, Calderon MA, et al., Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals. Allergy 2015; 70: 171-179.
75. Golebski K, Roschmann KI, Toppila-Salmi S, Hammad H, Lambrecht BN, Renkonen R, et al., The multi-faceted role of allergen exposure to the local airway mucosa. Allergy 2013; 68: 152-160.
76. Segboer CL, Holland CT, Reinartz SM, Terreehorst I, Gevorgyan A, Hellings PW, et al., Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy 2013; 68: 1427-1434.
77. Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al., Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2013; 68: 1-7.
78. Papadopoulos NG, Bernstein JA, Demoly P, Dykewicz M, Fokkens W, Hellings PW, et al., Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy 2015; 70: 474-494.
79. Calderon MA, Casale T, Cox L, Akdis CA, Burks AW, Nelson HS, et al., Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy. Asthma and Immunology/PRACTALL consensus report. Allergy 2013; 68: 825-828.
80. Scadding GW, Eifan AO, Lao-Araya M, Penagos M, Poon SY, Steveling E, et al., Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge. Allergy 2015; 70: 689-696.
81. Nestor CE, Dadfar E, Ernerudh J, Gustafsson M, Bjorkander J, Benson M, et al., Sublingual immunotherapy alters expression of IL-4 and its soluble and membrane-bound receptors. Allergy 2014; 69: 1564-1566.
82. Witting Christensen SK, Kortekaas Krohn I, Thuraiaiyah J, Skjold T, Schmid JM, Hoffmann HJ,. Sequential allergen desensitization of basophils is non-specific and may involve p38 MAPK. Allergy 2014; 69: 1343-1349.
83. Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, et al., Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014; 69: 854-867.
84. Pitsios C, Demoly P, Bilo MB, Gerth van Wijk R, Pfaar O, Sturm GJ, et al., Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy 2015; 70: 897-909.
85. Nony E, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, et al., Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Allergy 2015; 70: 795-804.
86. Meyer W, Narkus A, Salapatek AM, Hafner D,. Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber. Allergy 2013; 68: 724-731.
87. Senti G, von Moos S, Tay F, Graf N, Johansen P, Kundig TM,. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy 2015; 70: 707-710.
88. Sastre J, Rodriguez F, Campo P, Laffond E, Marin A, Alonso MD,. Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy 2015; 70: 598-600.
89. Maloney J, Durham S, Skoner D, Dahl R, Bufe A, Bernstein D, et al., Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma. Allergy 2015; 70: 302-309.
90. Nelson H, Blaiss M, Nolte H, Würtz SØ, Andersen JS, Durham SR,. Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects. Allergy 2013; 68: 252-255.
91. Pfaar O, Biedermann T, Klimek L, Sager A, Robinson DS,. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients. Allergy 2013; 68: 1306-1313.
92. van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al., The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008; 63: 310-326.
93. Moreno Benitez F, Espinazo RM, Letran CA, Mas S, Garcia-Cozar FJ, Tabar AI,. Variation in allergen content in Sublingual Allergen Immunotherapy (SLIT) with house dust mites (HDM). Allergy 2015; 70: 1413-1420.
94. Church MK, Maurer M, Simons FE, Bindslev-Jensen C, van Cauwenberge P, Bousquet J, et al., Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy 2010; 65: 459-466.
95. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
96. Mullol J, Bousquet J, Bachert C, Canonica WG, Gimenez-Arnau A, Kowalski ML, et al., Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008; 63 (Suppl 87): 5-28.
97. Mullol J, Bousquet J, Bachert C, Canonica GW, Giménez-Arnau A, Kowalski ML, et al., Update on rupatadine in the management of allergic disorders. Allergy 2015; 70: 1-24.
98. Spina D, Coyle AJ, Page CP,. The role of platelet activating factor in allergic inflammation. Pulm Pharmacol 1989; 2: 13-19.
99. Siebenhaar F, Fortsch A, Krause K, Weller K, Metz M, Magerl M, et al., Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial. Allergy 2013; 68: 949-952.
100. Krause K, Gimenez-Arnau A, Martinez-Escala E, Farre-Albadalejo M, Abajian M, Church MK, et al., Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation. Allergy 2013; 68: 256-258.
101. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al., The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868-887.
102. Krause K, Spohr A, Zuberbier T, Church MK, Maurer M,. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68: 921-928.
103. Choi SM, Park JE, Li SS, Jung H, Zi M, Kim TH, et al., A multicenter, randomized, controlled trial testing the effects of acupuncture on allergic rhinitis. Allergy 2013; 68: 365-374.
104. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al., EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 2015; 70: 727-754.
105. von Gunten S, Cortinas-Elizondo F, Kollarik M, Beisswenger C, Lepper PM,. Mechanisms and potential therapeutic targets in allergic inflammation: recent insights. Allergy 2013; 68: 1487-1498.
106. Kleinjan A, van Nimwegen M, Leman K, Hoogsteden HC, Lambrecht BN,. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. Allergy 2013; 68: 204-212.
107. Liu LY, Wang H, Xenakis JJ, Spencer LA,. Notch signaling mediates granulocyte-macrophage colony-stimulating factor priming-induced transendothelial migration of human eosinophils. Allergy 2015; 70: 805-812.
108. Fonseca DM, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, et al., Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy 2015; 70: 275-284.
109. Pettipher R, Hunter MG, Perkins CM, Collins LP, Lewis T, Baillet M, et al., Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459. Allergy 2014; 69: 1223-1232.
110. Straumann A, Hoesli S, Bussmann C, Stuck M, Perkins M, Collins LP, et al., Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy 2013; 68: 375-385.
111. Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Collins LP, Hunter MG, et al., The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy 2012; 67: 1572-1579.
112. Kang MG, Song WJ, Choi S, Kim H, Ha H, Kim SH, et al., Google unveils a glimpse of allergic rhinitis in the real world. Allergy 2015; 70: 124-128.
113. de Weger LA, Hiemstra PS, Op den Buysch E, van Vliet AJH,. Spatiotemporal monitoring of allergic rhinitis symptoms in the Netherlands using citizen science. Allergy 2014; 69: 1085-1091.
114. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al., MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy 2015; 70: 1372-1392.